Prosecution Insights
Last updated: October 04, 2026

Integenx Inc.

Technology areas: Biotechnology & Pharmaceuticals • Chemistry & Materials • Computing & Software

3 pending office actions • 3 art units • 3 examiners • 0 of 3 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days

Analysis

Integenx Inc. has 3 pending office actions within the Chemistry & Materials technology area. These matters are assigned to 3 distinct examiners and are being reviewed across a corresponding number of distinct art units. This ratio between pending actions, examiners, and art units indicates that every active case in the portfolio is being handled by a different individual in a different technical group.

The busiest examiner, QIAN, SHIZHI, is currently managing 1 busiest examiner pending action. Given the total count of pending office actions, no individual examiner holds a majority of the active cases. The use of the distinct examiners suggests a decentralized prosecution environment where each application is subject to a different examiner's perspective.

The distinct art units involved show that the company's chemistry and materials innovations are being evaluated by separate specialized divisions. This spread across examiners means that the company's legal strategy must account for independent sets of examiner preferences and timelines.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

3
Total Pending OAs
1
Non-Final OAs
1
Final Rejections
1
Advisory / Quayle

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

3
Hard (100%)
0
Medium (0%)
0
Easy (0%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§101 only1 (33%)
§101 + other1 (33%)
Multi-statute (no §101)1 (33%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

2
Life Sciences
67% of docket
1
Information Tech
33% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
0
Mechanical / Eng
0% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

30 h
Manual time on pending OAs
6 h
Time saved (low, 20%)
10 h
Time saved (mid, 35%)
0.3 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
QIAN, SHIZHI 1 61.8% +47.9%
SAX, STEVEN PAUL 1 69.0% +45.9%
GREENE, CAROLYN LEE 1 65.3% +47.3%

Hard Cases (3)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 3 ordered by deadline are shown.

App #TitleExaminerDue in
18814847 SYSTEMS AND METHODS FOR SAMPLE PREPARATION, PROCESSING AND ANALYSIS QIAN, SHIZHI —
18326519 SYSTEMS AND METHODS FOR LIVE HELP SAX, STEVEN PAUL —
17311263 CONTROLLING DNA CONCENTRATION FOR STR ANALYSIS GREENE, CAROLYN LEE —

Interview Candidates (3)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 3 ordered by deadline are shown.

App #TitleExaminerDue in
18814847 SYSTEMS AND METHODS FOR SAMPLE PREPARATION, PROCESSING AND ANALYSIS QIAN, SHIZHI —
18326519 SYSTEMS AND METHODS FOR LIVE HELP SAX, STEVEN PAUL —
17311263 CONTROLLING DNA CONCENTRATION FOR STR ANALYSIS GREENE, CAROLYN LEE —

Top Art Units

Art UnitApps
1795 1
2146 1
1681 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18814847 SYSTEMS AND METHODS FOR SAMPLE PREPARATION, PROCESSING AND ANALYSIS QIAN, SHIZHI 1795 §102§103 Non-Final OA — Pending Aug 26, 2024
18326519 SYSTEMS AND METHODS FOR LIVE HELP SAX, STEVEN PAUL 2146 §101§103§112Other Final Rejection — Pending May 31, 2023
17311263 CONTROLLING DNA CONCENTRATION FOR STR ANALYSIS GREENE, CAROLYN LEE 1681 §101 Non-Final OA — Pending Jun 04, 2021

Managing Integenx Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month